3-iodobenzylguanidine has been researched along with succinic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornelissen, J; Elzinga, L; Van den Bogert, C; Van Gennip, AH; Van Kuilenburg, AB; Voûte, PA; Wanders, RJ | 1 |
| Biaglow, J; Burd, R; Dewhirst, M; Leeper, D; Tuttle, S | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and succinic acid
| Article | Year |
|---|---|
Meta-iodobenzylguanidine (MIBG) inhibits malate and succinate driven mitochondrial ATP synthesis in the human neuroblastoma cell line SK-N-BE(2c).
Topics: 3-Iodobenzylguanidine; Adenosine Triphosphate; Antineoplastic Agents; Cell Division; Dose-Response Relationship, Drug; Humans; Iodobenzenes; Malates; Mitochondria; Neuroblastoma; Succinates; Succinic Acid; Tumor Cells, Cultured | 1995 |
Factors controlling oxygen utilization.
Topics: 3-Iodobenzylguanidine; Animals; Cell Line, Tumor; Diffusion; Female; Glioma; Glucose; Glutamine; Malonates; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Oxygen Consumption; Rats; Succinic Acid | 2005 |